Hyperlipidaemia induces ROS production through an NADPH oxidase‐dependent pathway that activates NLRP3 and caspase‐1, causing VEC pyroptosis and inflammation6, 79, 80 (Figure 3). The gene discussed is NLRP3; the disease is hyperlipidemia.